Bold Goals for Biomanufacturing: How Biomanufacturing Will Transform Human Health and Beyond

Event


Omni Boston Hotel at The Seaport
Contemporary Ballroom
450 Summer Street
Boston, Massachusetts 02210
Get Directionsplace

Al Gianchetti

Chief Executive Officer, XyloCor Therapeutics

Avi Nando

Chief Technology Officer, Center for Breakthrough Medicine

Jeffrey C. Baker, Ph.D

Senior Fellow, NIIMBL

Patti Seymour

Managing Director, BioProcess Technology Group, BDO USA, LLP

Sadik H. Kassim, Ph.D.

Chief Technology Officer, Genomic Medicine, Danaher Corporation

Contact

Stacey Lesanto

Emailmail

Technical Support

+1 844-580-6963

BDO Employees

+1 844-580-6963

Share

Event


Omni Boston Hotel at The Seaport
Contemporary Ballroom
450 Summer Street
Boston, Massachusetts 02210
Get Directionsplace

Contact

Stacey Lesanto

Emailmail

Technical Support

+1 844-580-6963

BDO Employees

+1 844-580-6963

Share

Related Events & Webcasts

Recording

Planning for a Return to Work: Considerations and Implications for the Life Sciences Industry

As the COVID-19 pandemic progresses, many executives are starting to rationalize how their teams safely return to work. With restrictions varying between regions and countries, it can be difficult to develop a comprehensive strategy. This challenge is further compounded by economic uncertainty and supplier dependencies.

View Recording
Recording

2020 BDO Biotech Briefing

BDO’s annual Biotech Briefing examines the most recent 10-K SEC filings of companies listed on the NASDAQ Biotechnology Index. Join us as we analyze this year's findings and trends in the marketplace

View Recording
Recording

Life Sciences and the Technical/GxP Virtual Audit – The Show Must Go On

In the face of COVID-19, the mission becomes even more critical. Innovation such as finding a way to continue to work without interruption due to CDC protocols, such as social distancing and travel bans, is imperative. Thanks to leveraging technology, we have made it possible to perform audits from a remote location, a method known as the “virtual audit”.

View Recording
Recording

Federal Government Funding Opportunities for the Life Sciences Industry

The federal government has prioritized R&D for Covid-19 response efforts and will continue to do so until the health threat has been addressed. As these countermeasures are developed and deployed, the federal government’s biodefense R&D resources will be re-prioritized to address chemical, biological, radiological and nuclear threats, influenza and other emerging infectious diseases.

View Recording
Recording

What’s Next for SPACs in the Life Sciences Industry? A Discussion with Ginkgo Bioworks

With over 200 SPAC and IPO’s over the last year, SPACs are hotter than ever. US stocks continue to be unpredictable, finding the right opening to debut on Wall Street can be tricky and costly. But are SPAC’s the right approach for most Life Sciences companies seeking capital.

View Recording
Recording

The Evolving Federal Funding Landscape and Business Implications for the Life Sciences Industry

As Federal Government Agencies tasked with biodefense and public health continue response efforts to the acute phase of the COVID-19 pandemic, each Agency continues to balance strategic legacy initiatives and new fiscal year priorities.

View Recording
Recording

HIPAA Privacy and Security: Recent Trends in Regulation, Enforcement, and Risk Management

Join this first webinar of BDO’s Healthcare and Life Sciences Data Protection Webinar Series to learn more about how organizations can address their efficiency, risk, and governance challenges by aligning approaches and functions to optimize compliance and leverage available protections.

View Recording
Recording

Health Apps and HIPAA Business Associates’ Rising Obligations in Privacy and Health Data

Join our second webcast of BDO’s Healthcare and Life Sciences Data Protection Webinar Series to learn more about how organizations can address their efficiency, risk, and governance challenges by aligning approaches and functions to optimize compliance and leverage available protections.

View Recording
Recording

Interpretation of BARDA’s Priorities for 2023: Preparedness for the Next Pandemic Threat

This webinar will provide a review of the highlights from BARDA Industry Day 2022, presentation of new initiatives to support pandemic preparedness, and recommendations of best practices for potential partners to be well positioned to respond to new opportunities.

View Recording
Recording

Privacy and Website Compliance - Cookies, Consent, Tracking, Oh My!

Join the final webcast of BDO’s Healthcare and Life Sciences Data Protection Webinar Series to learn more about how organizations can address their efficiency, risk, and governance challenges by aligning approaches and functions to optimize compliance and leverage available protections.

View Recording
Webcast

Taking Stock of Private Equity Mid-2023

Join BDO’s Private Equity Leaders for a discussion on where private equity sits midway through the year, informed by takeaways from our latest survey of more than 400 fund managers and operating partners and 250 portfolio company CFOs and board members.

Register
See All Events & Webcastschevron_right